Dr. Martens plc (LON:DOCS – Get Free Report)’s stock price was down 0.5% during mid-day trading on Friday. The stock traded as low as GBX 62.80 and last traded at GBX 64. Approximately 1,609,215 shares changed hands during trading, a decline of 74% from the average session volume of 6,116,622 shares. The stock had previously closed at GBX 64.30.
Wall Street Analyst Weigh In
Separately, Berenberg Bank reissued a “buy” rating and issued a GBX 110 price target on shares of Dr. Martens in a research report on Friday, October 9th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 105.
View Our Latest Stock Report on DOCS
Dr. Martens Trading Down 0.5%
The company has a debt-to-equity ratio of 108.85, a current ratio of 2.61 and a quick ratio of 1.13. The firm has a market capitalization of £612.65 million, a price-to-earnings ratio of 26.67, a PEG ratio of 6.40 and a beta of 0.26. The business has a 50 day moving average of GBX 67.82 and a 200 day moving average of GBX 69.70.
Insiders Place Their Bets
In related news, insider Ije Nwokori sold 209,160 shares of Dr. Martens stock in a transaction dated Friday, October 16th. The stock was sold at an average price of GBX 69, for a total value of £144,320.40. Insiders have acquired a total of 810 shares of company stock valued at $60,112 over the last ninety days. 2.97% of the stock is currently owned by company insiders.
About Dr. Martens
Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot – named after the date it was produced – rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, “Docs” or “DM’s” were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.
Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people.
Recommended Stories
- Five stocks we like better than Dr. Martens
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
